Metavirome Identification and Pathogenicity Evaluation of Tibet Orbivirus in Pigs
Transboundary and Emerging Diseases · 2025
DOI: 10.1155/tbed/6628384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, 2025. Verfasst von Zhanhong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yunnan Tropical and Subtropical Animal Virus Diseases Laboratory, Yunnan Animal Science and Veterinary Institute, Kunming, China. Hauptthemen laut MEDLINE: Swine Diseases, Reoviridae Infections, Orbivirus. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tibet orbivirus (TIBOV) is an orbivirus transmitted by mosquitoes and Culicoides , despite specific neutralizing antibodies being detected in pigs, but the molecular genetic characteristics of TIBOV strains in infected pigs are completely uncharted, and their pathogenicity in piglets is poorly elucidated. This study aimed to investigate the genetic characteristics of TIBOV in infected pigs and evaluate the pathogenicity of TIBOV in weaned piglets. Through viral metagenomic sequencing, seven segments (VP1‐VP4, VP6, NS1, and NS2) of TIBOV were obtained from swine tissues, and the sequences showed high identity with TIBOVs isolated from Culicoides , mosquitos, and cattle. After infection with TIBOV, the body temperature, appetite, and behavior of the piglets were normal, whereas hemorrhage nodes were observed on the hooves of all piglets and on the abdominal skin of one pig. Viremia was first detected at 2 days postinfection (dpi), peaked at 6 dpi, and remained high until 21 dpi. The virus was distributed in multiple organs, and the highest viral load and strongest viral nucleic acid signals were observed in the spleen. The most severe lesion was observed in the spleen with white pulp atrophy, a decreased number of lymphocytes, and widened septa of the medullary cord, indicating that the spleen was the most important target organ of TIBOV infection. The levels of inflammatory cytokines, including interleukin (IL)‐18, tumor necrosis factor‐α (TNF‐α), interferon (IFN)‐α, and IFN‐λ3 in peripheral blood lymphocytes decreased significantly from 2 to 6 dpi, and interferon‐stimulated gene‐15 ( ISG-15 ) and IFN regulatory factor 7 ( IRF-7 ) expression levels declined significantly from 2 to 9 dpi, suggesting that the host immune response was inhibited within 6 dpi. Our findings confirmed that TIBOV elicited long‐term viremia with mild clinical symptoms in piglets, the spleen was the target organ of TIBOV proliferation, and the host immune response may be slightly inhibited in the early stage of viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yunnan Tropical and Subtropical Animal Virus Diseases Laboratory, Yunnan Animal Science and Veterinary Institute, Kunming, China.
- Key Laboratory of Transboundary Animal Diseases Prevention and Control (Co-construction by Ministry and Province), Ministry of Agriculture and Rural Affairs, Kunming, China.
- Mile Preventive and Control Center for Animal Diseases, Taoyuan Road, Mile, China.
- Honghe Preventive and Control Center for Animal Diseases, Zhongzhao Road, Mengzi, China.
ORCID-Profile: Zhanhong Li, Jianling Song
Zitieren
APA
Li, Z., Zhu, P., Zhang, Z., Li, Z., Liu, P., Meng, L., Yang, Q., Yang, Z., & Song, J. (2025). Metavirome Identification and Pathogenicity Evaluation of Tibet Orbivirus in Pigs. Transboundary and Emerging Diseases. https://doi.org/10.1155/tbed/6628384
Vancouver
Li Z, Zhu P, Zhang Z, Li Z, Liu P, Meng L, et al. Metavirome Identification and Pathogenicity Evaluation of Tibet Orbivirus in Pigs. Transboundary and Emerging Diseases. 2025. doi:10.1155/tbed/6628384
BibTeX
@article{Li2025,
author = {Li, Zhanhong and Zhu, Pei and Zhang, Zhenxing and Li, Zhuoran and Liu, Peng and Meng, Li and Yang, Qiuyan and Yang, Zhen and Song, Jianling},
title = {Metavirome Identification and Pathogenicity Evaluation of Tibet Orbivirus in Pigs},
journal = {Transboundary and Emerging Diseases},
year = {2025},
doi = {10.1155/tbed/6628384}
}
EUVIMED